A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
Nonalcoholic Fatty Liver Disease (NAFLD)
Statin Initiation Reduces Risk for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Researchers examined the association between initiating statin therapy and the risk for HCC in patients with NAFLD.
Metabolic Dysfunction-Related Fatty Liver Disease Increases Risk for Colon Cancer
Researchers analyzed the relationship between metabolic dysfunction-associated fatty liver disease and the risk for colon cancer.
Increased Physical Activity May Reduce Risk for NAFLD
Investigators assessed the effects of different levels of physical activity on the prevalence of nonalcoholic fatty liver disease and its association with metabolic health.
Statin Use May Decrease Cancer-Related Mortality in Nonalcoholic Fatty Liver Disease
Researchers evaluated the effects of statin use on cancer mortality in patients with nonalcoholic fatty liver disease.
Bidirectional Association Identified for NAFLD and Psoriasis
There is a bidirectional association between nonalcoholic fatty liver disease and psoriasis, especially for patients younger than 40 years.
NAFLD May Raise Risk for Severe Hypoglycemia in T2DM
Nonalcoholic fatty liver disease is associated with a higher risk for severe hypoglycemia in patients with type 2 diabetes.
Efficacy of Antihyperglycemic Drugs for the Treatment of NAFLD and NASH
Investigators examined the effects of certain antihyperglycemic drugs as treatment for NAFLD or NASH in patients with or without type 2 diabetes.
Lean Patients at Similar Risk for Poor Outcomes, Mortality as Patients Classified As Non-Lean With NAFLD
Investigators assessed baseline characteristics and long-term outcomes of White patients classified as lean with nonalcoholic fatty liver disease.
DMR Significantly Improves Glycemic Control and Reduces Liver Fat Content in T2D
Investigators assessed the efficacy and safety of duodenal mucosal resurfacing vs a sham endoscopic procedure in patients with type 2 diabetes with or without NAFLD.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...